173 related articles for article (PubMed ID: 7538415)
1. Localization of multiple functional domains on human PECAM-1 (CD31) by monoclonal antibody epitope mapping.
Yan HC; Pilewski JM; Zhang Q; DeLisser HM; Romer L; Albelda SM
Cell Adhes Commun; 1995 Feb; 3(1):45-66. PubMed ID: 7538415
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment.
Nakada MT; Amin K; Christofidou-Solomidou M; O'Brien CD; Sun J; Gurubhagavatula I; Heavner GA; Taylor AH; Paddock C; Sun QH; Zehnder JL; Newman PJ; Albelda SM; DeLisser HM
J Immunol; 2000 Jan; 164(1):452-62. PubMed ID: 10605042
[TBL] [Abstract][Full Text] [Related]
3. Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression.
Sun J; Williams J; Yan HC; Amin KM; Albelda SM; DeLisser HM
J Biol Chem; 1996 Aug; 271(31):18561-70. PubMed ID: 8702505
[TBL] [Abstract][Full Text] [Related]
4. Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity.
Sun QH; DeLisser HM; Zukowski MM; Paddock C; Albelda SM; Newman PJ
J Biol Chem; 1996 May; 271(19):11090-8. PubMed ID: 8626652
[TBL] [Abstract][Full Text] [Related]
5. Deletions in the cytoplasmic domain of platelet-endothelial cell adhesion molecule-1 (PECAM-1, CD31) result in changes in ligand binding properties.
DeLisser HM; Chilkotowsky J; Yan HC; Daise ML; Buck CA; Albelda SM
J Cell Biol; 1994 Jan; 124(1-2):195-203. PubMed ID: 8294502
[TBL] [Abstract][Full Text] [Related]
6. Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1.
Liao F; Huynh HK; Eiroa A; Greene T; Polizzi E; Muller WA
J Exp Med; 1995 Nov; 182(5):1337-43. PubMed ID: 7595204
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1).
Yan HC; Baldwin HS; Sun J; Buck CA; Albelda SM; DeLisser HM
J Biol Chem; 1995 Oct; 270(40):23672-80. PubMed ID: 7559536
[TBL] [Abstract][Full Text] [Related]
8. Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain.
Kirschbaum NE; Gumina RJ; Newman PJ
Blood; 1994 Dec; 84(12):4028-37. PubMed ID: 7994021
[TBL] [Abstract][Full Text] [Related]
9. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development.
Baldwin HS; Shen HM; Yan HC; DeLisser HM; Chung A; Mickanin C; Trask T; Kirschbaum NE; Newman PJ; Albelda SM
Development; 1994 Sep; 120(9):2539-53. PubMed ID: 7956830
[TBL] [Abstract][Full Text] [Related]
10. Identification of the ligand-binding domains of CD22, a member of the immunoglobulin superfamily that uniquely binds a sialic acid-dependent ligand.
Engel P; Wagner N; Miller AS; Tedder TF
J Exp Med; 1995 Apr; 181(4):1581-6. PubMed ID: 7535343
[TBL] [Abstract][Full Text] [Related]
11. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.
Piali L; Hammel P; Uherek C; Bachmann F; Gisler RH; Dunon D; Imhof BA
J Cell Biol; 1995 Jul; 130(2):451-60. PubMed ID: 7542249
[TBL] [Abstract][Full Text] [Related]
12. Platelet/endothelial cell adhesion molecule-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans.
DeLisser HM; Yan HC; Newman PJ; Muller WA; Buck CA; Albelda SM
J Biol Chem; 1993 Jul; 268(21):16037-46. PubMed ID: 8340425
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide.
Zehnder JL; Shatsky M; Leung LL; Butcher EC; McGregor JL; Levitt LJ
Blood; 1995 Mar; 85(5):1282-8. PubMed ID: 7858258
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional aspects of PECAM-1/CD31.
DeLisser HM; Newman PJ; Albelda SM
Immunol Today; 1994 Oct; 15(10):490-5. PubMed ID: 7945775
[TBL] [Abstract][Full Text] [Related]
15. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18).
Berman ME; Muller WA
J Immunol; 1995 Jan; 154(1):299-307. PubMed ID: 7995949
[TBL] [Abstract][Full Text] [Related]
16. Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation.
Berman ME; Xie Y; Muller WA
J Immunol; 1996 Feb; 156(4):1515-24. PubMed ID: 8568255
[TBL] [Abstract][Full Text] [Related]
17. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily.
Newman PJ; Berndt MC; Gorski J; White GC; Lyman S; Paddock C; Muller WA
Science; 1990 Mar; 247(4947):1219-22. PubMed ID: 1690453
[TBL] [Abstract][Full Text] [Related]
18. Divergent effects of platelet-endothelial cell adhesion molecule-1 and beta 3 integrin blockade on leukocyte transmigration in vivo.
Thompson RD; Wakelin MW; Larbi KY; Dewar A; Asimakopoulos G; Horton MA; Nakada MT; Nourshargh S
J Immunol; 2000 Jul; 165(1):426-34. PubMed ID: 10861081
[TBL] [Abstract][Full Text] [Related]
19. Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 2. Biochemical analyses.
Coombe DR; Stevenson SM; Kinnear BF; Gandhi NS; Mancera RL; Osmond RI; Kett WC
Biochemistry; 2008 Apr; 47(17):4863-75. PubMed ID: 18327914
[TBL] [Abstract][Full Text] [Related]
20. The role of PECAM-1 in vascular cell biology.
Newman PJ
Ann N Y Acad Sci; 1994 Apr; 714():165-74. PubMed ID: 8017765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
